The usual things for fund are deals in the range of 50 - 100 millions dollars. The important activity for fund was in 2004. The higher amount of exits for fund were in 2007. The fund is constantly included in less than 2 deals per year.
The typical case for the fund is to invest in rounds with 6 participants. The meaningful sponsors for the fund in investment in the same round are SunAmerica, Mountain Trail Investments, Galleon Group.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Pharmaceutical, Medical. Among the most popular portfolio startups of the fund, we may highlight Synta Pharmaceuticals.
| Fund Name | Location |
| 1to4 Foundation | - |
| American General Financial Group | - |
| Ankang Venture Investment | - |
| Aoou Wangluo Keji | China, Shanghai |
| Asimov Capital Partners | - |
| Balance Ventures | California, San Francisco, United States |
| BitAngels | Las Vegas, Nevada, United States |
| Blackfoot | Missoula, Montana, United States |
| BVF Partners | California, San Francisco, United States |
| Club Invest 77 | France, Ile-de-France, Serris |
| GU Equity Partners | - |
| Hike | Delhi, India, New Delhi |
| Jupiter Capital | Bangalore, India, Karnataka |
| Masters Capital Nanotechnology | Chicago, Illinois, United States |
| RAD Data Communications | Israel, Tel Aviv, Tel Aviv District |
| Singularity Ventures | Chennai, India, Tamil Nadu |
| SPARK VCT | England, London, United Kingdom |
| Tennenbaum Capital Partners | California, Santa Monica, United States |
| Whales Capital | China, Shanghai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Synta Pharmaceuticals | $50M | 14 Jan 2004 | Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Synta Pharmaceuticals | $50M | 14 Jan 2004 | Massachusetts, United States |
